TC
MGNX icon

Truvestments Capital’s MacroGenics MGNX Stock Holding History

Truvestments Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462 Sell
160
-848
-84% -$1.81K ﹤0.01% 1093
2025
Q4 		$1.62K Hold
1,008
– – ﹤0.01% 894
2025
Q3 		$1.69K Sell
1,008
-1,390
-58% -$2.25K ﹤0.01% 933
2025
Q2 		$2.9K Hold
2,398
– – ﹤0.01% 797
2025
Q1 		$3.04K Sell
2,398
-491
-17% -$1.28K ﹤0.01% 816
2024
Q4 		$9.39K Buy
2,889
+1,861
+181% +$6.7K ﹤0.01% 617
2024
Q3 		$3.38K Buy
+1,028
New +$4K ﹤0.01% 731

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Truvestments Capital's MGNX Position: Q1 2026 in Review

Truvestments Capital reduced its MacroGenics (MGNX) stake by 84% in Q1 2026, selling an estimated $1.81K and leaving 160 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Truvestments Capital first reported a position in MGNX in Q3 2024 and has held it in 7 quarters since. The position peaked at $9.39K in Q4 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Truvestments Capital held 160 shares of MacroGenics worth $462 as of Q1 2026.
  • Truvestments Capital sold 848 MacroGenics shares in Q1 2026, an estimated $1.81K.
  • MacroGenics made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1093 holding.
  • Truvestments Capital first reported a position in MacroGenics in Q3 2024 and has held it in 7 quarters since.
  • Truvestments Capital's MacroGenics position peaked at $9.39K in Q4 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.